Active, Not Recruiting
Investigate the Efficacy and Safety of BRII-835 (VIR-2218) and PEG-IFNα Combination Therapy in Chronic HBV Patients
NCT05970289
- Conditions
- Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B Virus Infection, +15 more
- Locations
-
- Investigative Site 61001 Kingswood, New South Wales, Australia
- Investigative Site 61002 Birtinya, Queensland, Australia
- Investigative Site 61003 Melbourne, Victoria, Australia
- Investigative Site 86001 Beijing, Beijing Municipality, China